Country of origin

Riociguat | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Riociguat. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Shanghai Bncscitech Co., Ltd

MOQ: 1 kg
Type: Producer
Origin: China

Type: Producer
Origin: Germany
Alembic Pharma

Type: Producer
Origin: India
MSN Life Sciences

Type: Producer
Origin: India

Looking for Riociguat 625115-55-1?

API | Excipient name:
Cas Number:
DrugBank number:
Unique Ingredient Identifier:

About Riociguat

What can you use it for? Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for the treatment of patients with inoperable CTEPH (chronic thromboembolic pulmonary hypertension), or persistent/recurrent PH (pulmonary hypertension) after pulmonary endarterectomy in WHO FC II or III. Riociguat is marketed under the brand Adempas® by Bayer HealthCare Pharmaceuticals. Treatment with riociguat costs USD $700 for 30 days of treatment.

You can find more info about this product by clicking on the DB ID above.

Riociguat manufacturers | traders | suppliers
We have 4 companies offering Riociguat from 3 different countries.

Get in contact with the supplier of your choice:

  • Shanghai Bncscitech Co., Ltd from China
  • Bayer from Germany
  • Alembic Pharma from India
  • MSN Life Sciences from India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.